• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search Back To Search Results
Recognition List Number: 028 Publication Date: 03/16/2012 

Part B: SUPPLEMENTARY INFORMATION

Recognition Number 12-236: IEC 60601-2-45 Edition 3.0 2011-02, Medical electrical equipment - Part 2-45: Particular requirements for the basic safety and essential performance of mammographic X-ray equipment and mammographic stereotactic devices. (Radiology)

Date of Standard: 2011. 
Address of Standards Organization:
  International Electrotechnical Commission (IEC)
  3, Rue de Varembe'
  PO Box 131
  CH-1211 Geneva 20, 0
  SWITZERLAND
CDRH Office and Division Associated with Recognized Standards:
ALL OFFICES AND DIVISIONS IN CDRH
Devices Affected:
Mammographic X-ray Equipment
Processes Affected:
510(k), PMA, IDE, HDE, MQSA
Type of Standard:
 Vertical, International
Extent of Recognition:
Complete standard

Transition:
FDA recognition of IEC 60601-2-45 Ed. 2.0 (2001) is hereby superseded by recognition of IEC 60601-2-45 Edition 3.0 2011-02 Medical electrical equipment ? Part 2-45: Particular requirements for the basic safety and essential performance of mammographic X-ray equipment and mammographic stereotactic devices. FDA will accept declarations of conformity, in support of premarket submissions, to IEC 60601-2-45 Ed. 2.0 (2001) until June 30, 2013. After this transitional period, declarations of conformity to Ed. 2.0 (2001) of the standard will not be accepted.
Related CFR Citations and Product Codes:
Regulation
Number
Device Name Device
Class
Product
Code
§892.1710 System, X-Ray, Mammographic Class 2 IZH
 
Relevant Guidance:
There is no relevant guidance developed at this time.
FDA Technical Contact:
  Kish Chakrabarti
  FDA/CDRH/OIVD
  10903 New Hampshire Avenue Building 66, Room G308
  Silver Spring MD 20993
  301/796-6539
  Email: kish.chakrabarti@fda.hhs.gov
* In the United States, copies of this standard can be obtained from:
  American National Standards Institute (ANSI)*
  25 West 43rd Street
  4th Floor
  New York, NY 10036
-
-